Compare TRST & VOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TRST | VOR |
|---|---|---|
| Founded | 1902 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 834.0M | 702.4M |
| IPO Year | 1994 | 2021 |
| Metric | TRST | VOR |
|---|---|---|
| Price | $47.57 | $14.71 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 10 |
| Target Price | N/A | ★ $45.33 |
| AVG Volume (30 Days) | 67.9K | ★ 1.0M |
| Earning Date | 04-21-2026 | 05-11-2026 |
| Dividend Yield | ★ 3.25% | N/A |
| EPS Growth | ★ 26.46 | N/A |
| EPS | ★ 3.25 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $14.58 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $30.17 | $0.13 |
| 52 Week High | $48.45 | $49.95 |
| Indicator | TRST | VOR |
|---|---|---|
| Relative Strength Index (RSI) | 64.22 | 49.33 |
| Support Level | $44.46 | $11.74 |
| Resistance Level | N/A | $14.73 |
| Average True Range (ATR) | 1.27 | 0.96 |
| MACD | 0.14 | -0.10 |
| Stochastic Oscillator | 100.00 | 33.13 |
Trustco Bank Corp N Y is a savings and loan holding company. The core part of a business consists of accepting deposits and making loans and investments. It offers a range of both personal and business banking services. The company's product includes savings accounts; retirement accounts; money market account; mortgages; building loans; auto loans and others. The company derives revenue from the business of Banking. TrustCo lends in the geographic territory of its branch locations in New York, Florida, Massachusetts, New Jersey, and Vermont.
Vor Biopharma Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of autoimmune diseases. Its program, telitacicept, is a potential first- and best-in-class dual BAFF/APRIL inhibitor designed to suppress the signaling pathways that drive the maturation, proliferation, and survival of harmful B cells, including self-reactive B cells, thereby reducing autoantibody production and preventing downstream tissue damage.